Pricing Log in Create free account

Nutriband Inc. (NTRB) vs Rani Therapeutics Holdings, Inc. (RANI)

Nutriband Inc. and Rani Therapeutics Holdings, Inc. are both Biotechnology companies. Nutriband Inc. and Rani Therapeutics Holdings, Inc. are of similar size ($72.0M and $67.8M). Rani Therapeutics Holdings, Inc. grew revenue faster over the last twelve months: 78.7% against −37.3%. Nutriband Inc. has the higher net margin (−430.4% vs −597.0%) and the lower return on invested capital (−227.9% vs 0.00%). Across the 17 metrics below, Rani Therapeutics Holdings, Inc. leads on 10 and Nutriband Inc. on 7.

Valuation

Metric NTRB RANI Biotechnology median
P/E n/m n/m 10.60
P/S 41.86 20.02 9.40
P/B 12.71 2.11 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 39.80 12.57 9.02
Earnings yield (10.28%) (50.00%) (32.88%)
Free cash flow yield (5.37%) (20.12%) (23.13%)

Profitability

Metric NTRB RANI Biotechnology median
Gross margin 33.14% 100.00% 68.51%
Operating margin (435.57%) (652.78%) 0.00%
Net margin (430.43%) (596.97%) 0.00%
Free cash flow margin (224.54%) (402.83%) 0.00%
Return on equity (100.79%) (155.24%) (51.96%)
Return on assets (84.56%) (77.54%) (46.06%)
Return on invested capital (227.92%) 0.00% 0.00%

Growth

Metric NTRB RANI Biotechnology median
Revenue growth (TTM) (37.25%) 78.73% 6.76%
EPS growth (last fiscal year) (160.61%) 57.14% 29.88%
Revenue growth, 5-year CAGR 16.63% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NTRB RANI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.21 5.31 4.97
Net debt to EBITDA 0.56 1.33 1.01

Dividend

Metric NTRB RANI Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NTRB RANI Biotechnology median
Market cap 67.77m 71.96m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack